newsfilter
← Latest News
GlobeNewswire·

Scopus BioPharma Retaining Counsel to Investigate Unusual Market Activity

NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: "SCPS"), a clinical-stage biopharmaceutical company, announced today that it is retaining Boies Schiller Flexner LLP to conduct a market manipulation investigation. In the pa